skip to main content

CCB ankle oedema — GPhC CRA MCQ

Instant feedback + full explanation. One question, done properly.

EasyCardiovascular TherapeuticsCCB ankle oedemaGPhC CRA

A patient taking amlodipine 10 mg reports new ankle swelling after a dose increase. They have no breathlessness, calf pain or chest symptoms. What is the most appropriate action?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: B — Discuss likely dose-related oedema and refer for review

Dihydropyridine calcium-channel blockers can cause peripheral oedema, often dose-related. The medicine should not be stopped abruptly without review, but the prescriber should consider dose adjustment or alternatives. In this scenario, the correct option is discuss likely dose-related oedema and refer for review. The other options are plausible but do not address the key clinical, legal or safety issue as directly. This aligns with UK pharmacy practice guidance cited in the reference field.

Reference: BNF